diabetes

A randomized clinical trial compared tirzepatide with intensified standard care approaches in adults with a recent type 2 diabetes (T2D) diagnosis that was not adequately controlled on metformin alone.

A new “Trojan horse” weight-loss drug sneaks extra metabolic power into cells and delivers striking results in mice. Researchers at Helmholtz Munich have developed a new drug strategy that could improve treatment for obesity and type 2 diabetes. Led by metabolism scientist Prof Timo D. Müller, the team created a hybrid molecule that uses the [...]

A newly published review article highlights the emerging importance of the immunoproteasome in the development and progression of diabetes and its wide-ranging complications, offering fresh perspectives on future therapeutic strategies.

A large new study suggests that even people with a high genetic risk for type 2 diabetes may be able to greatly lower their chances of developing the disease by following healthier lifestyles. The research, led by scientists at the University of Massachusetts Amherst, found that lifestyle habits such as maintaining a healthy body weight, […] The post Healthy Habits May Overcome Genetic Risk for T…

Nature Reviews Drug Discovery, Published online: 22 May 2026; doi:10.1038/d41573-026-00087-5 Incretin-based multi-agonist reverses obesity and diabetes

Identifying children with early signs of type 1 diabetes makes a difference to their health. A new study suggests wider screening is effective.

The post Postpartum Diabetes Care Falls Short as Many Women Skip Essential A1C Testing appeared first on Association of Schools and Programs of Public Health (ASPPH) .

HonorHealth Research Institute is looking to become the first research facility in the nation to begin a new clinical trial that aims to modify the lining of the digestive tract with the use of steam energy to control type II diabetes without the use of drugs.

Doctors have warned for years that type 2 diabetes is spreading quickly across the world. Millions of people now live with the disease, and many more are expected to develop it in the future. Diabetes can quietly damage the body for years before serious problems appear. It increases the risk of heart disease, kidney failure, […] The post A a smarter Mediterranean diet can cut diabetes risk by nea…

Type 2 diabetes is one of the most common long-term health conditions in the world. It happens when the body cannot properly use insulin, a hormone that helps control blood sugar levels. Over time, high blood sugar can damage blood vessels, nerves, the heart, kidneys, and other organs. Because of this, people with type 2 […] The post Hidden heart dangers for people with type 2 diabetes revealed i…

Metformin is one of the world’s most widely used medicines for type 2 diabetes. Doctors have prescribed it for decades, and for many people it is the first medicine they receive after being diagnosed with the disease. Type 2 diabetes happens when the body can no longer use insulin properly or cannot make enough insulin […] The post Why millions of people with diabetes trust drug metformin appeare…

Journal of Computer Science, Published online: 19 May 2026; doi:10.3844/ojbsci.2026.26.02.026 Diabetic Nephropathy (DN) is a complex health condition that leads to various kidney diseases. According to the World Health Organization, over 2 million deaths have been reported due to diabetes and ...

Type 2 diabetes is one of the most common health problems in the world. It happens when the body can no longer use insulin properly. Insulin is a hormone that helps move sugar from the blood into the body’s cells, where it is used for energy. When insulin does not work well, sugar builds up […] The post Doctors reveal the worst foods for type 2 diabetes—and what to eat instead appeared first on K…

Exclusive: People from deprived and minority ethnic backgrounds have better access to device than for previous technologies The rollout of a “life-changing” artificial pancreas on the NHS for people with type 1 diabetes has helped to narrow ethnic and socioeconomic inequality within access to treatment, according to figures. Officially known as a hybrid closed-loop system, an artificial pancreas …

Disease-modifying therapies for type 1 diabetes are beginning to move care beyond insulin replacement by targeting immune dysregulation, beta-cell stress, and preservation of endogenous beta-cell function. Teplizumab marks a major clinical milestone, but the review emphasizes that durable metabolic remission will likely require earlier screening, better patient selection, and sequential or combin…

For decades, scientists believed that metformin, one of the world’s most widely used drugs for Type 2 Diabetes, mainly worked by targeting the liver to reduce sugar production. But a new study from Northwestern University suggests the drug’s real power may actually come from the gut. The study, published in Nature Metabolism, found that metformin […] The post Scientists discover metformin may wor…

Researchers from the University of Geneva (UNIGE) and Geneva University Hospitals (HUG) have reached a significant advance in the fight against type 1 diabetes. Using an innovative hydrogel that supports insulin-producing cells once transplanted into the body, the team successfully regulated blood sugar levels in diabetic mice.

If your Diabetes Care submission shows Under Review, here is what the ADA Editor-in-Chief and Associate Editor are doing during each stage and when to follow up.

If your Diabetes submission shows Under Review, here is what the ADA Editor-in-Chief and Associate Editor are doing during each stage and when to follow up.